Related Experiment Video
Updated: Jun 27, 2026
08:02
Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Published on: July 27, 2022
Phospholipase Cgamma1 is required for metastasis development and progression
Gianluca Sala1, Francesco Dituri, Claudio Raimondi
1Inositide Signalling Group, Centre for Diabetes and Metabolic Medicine, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, London, United Kingdom.
Cancer Research
|December 17, 2008
Summary
Phospholipase Cgamma1 (PLCgamma1) is crucial for cancer cell invasion and metastasis. Inhibiting PLCgamma1 significantly reduces tumor spread and offers potential therapeutic strategies for treating metastatic cancer.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Cell motility and invasion are key processes in metastasis.
- Phospholipase Cgamma1 (PLCgamma1) is implicated in tumor progression and metastasis.
Purpose of the Study:
- To investigate the role of PLCgamma1 in cancer cell invasion and metastasis.
- To evaluate the therapeutic potential of targeting PLCgamma1 in metastasis.
Main Methods:
- Down-regulation of PLCgamma1 expression in breast cancer and U87 cell lines.
- In vitro assays for cell invasion and small GTP-binding protein Rac activation.
- In vivo experimental metastasis assays in nude mice.
- Analysis of PLCgamma1 expression in patient tumor tissues.
Main Results:
- Down-regulation of PLCgamma1 impaired Rac activation and cell invasion in vitro.
- Inducible knockdown of PLCgamma1 significantly inhibited lung metastasis formation in vivo.
- Increased PLCgamma1 expression was observed in metastatic tissues compared to primary tumors in 50% of patients.
- PLCgamma1 plays a critical role in the metastatic potential of cancer cells.
Conclusions:
- PLCgamma1 is essential for cancer cell invasion and metastasis.
- Targeting PLCgamma1 presents a potential therapeutic strategy for inhibiting metastasis dissemination.
More Related Videos
Related Concept Videos
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
01:12What are Second Messengers?
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...